References
- Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368–78.
- Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.
- Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017;13(2):60–3.
- Danzi S, Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am. 2014;43(2):517–28.
- Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin e Investig en Arterioscler. 2014;26(6):296–309.
- Ellis ER, Josephson ME. What About Tachycardia-induced Cardiomyopathy? Arrhythmia Electrophysiol Rev. 2013;2(2):82–90.
- Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020:ehaa575.
- Her K, Choi CW, Park YW, Shin HK, Won YS. Concomitant Peripheral Artery Disease and Asymptomatic Coronary Artery Disease: A Management Strategy. Ann Vasc Surg. 2008;22(5):649–56.
- Adán V, Crown LA. Diagnosis and treatment of sick sinus syndrome. Am Fam Physician. 2003;67(8):1725–32.
- Klaeboe LG, Edvardsen T. Echocardiographic assessment of left ventricular systolic function. J Echocardiogr. 2019;17(1):10–6.
- Kusunose K, Torii Y, Yamada H, et al. Clinical Utility of Longitudinal Strain to Predict Functional Recovery in Patients With Tachyarrhythmia and Reduced LVEF. JACC Cardiovasc Imaging. 2017;10(2):118–26.
- Han FT, Kiser R, Nixon J V., Wood MA, Ellenbogen KA. What is the time course of reversal of tachycardia-induced cardiomyopathy? Europace. 2011;13(1):139–41.
- Mueller KAL, Heinzmann D, Klingel K, et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol. 2017;69(17):2160–72.
- Addison D, Farhad H, Shah R V., et al. Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation. J Am Heart Assoc. 2016;5(9):e003570.
- Neilan TG, Shah R V., Abbasi SA, et al. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation. J Am Coll Cardiol. 2013;62(23):2205–14.
- Curtis AB, Worley SJ, Adamson PB, et al. Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction. N Engl J Med. 2013;368(17):1585–93.
- Gasparini M, Leclercq C, Lunati M, et al. Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation. The CERTIFY Study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Hear Fail. 2013;1(6):500–7.
- Watanabe H, Okamura K, Chinushi M, et al. Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy. Int Heart J. 2008;49(1):39–47.